Skip to Content

M 120 (Abacavir sulfate 300 mg (base))

Pill imprint M 120 has been identified as Abacavir sulfate 300 mg (base).

Abacavir is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Abacavir sulfate 300 mg (base) M 120
Abacavir sulfate
M 120
300 mg (base)
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Mylan Pharmaceuticals Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.